Striatal Volume Increase After Six Weeks of Selective Dopamine D

SPECT antipsychotic drug dopamine receptor first-episode antipsychotic-naïve longitudinal sMRI schizophrenia striatum

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2020
Historique:
received: 31 01 2020
accepted: 20 04 2020
entrez: 9 6 2020
pubmed: 9 6 2020
medline: 9 6 2020
Statut: epublish

Résumé

Patients with chronic schizophrenia often display enlarged striatal volumes, and antipsychotic drugs may contribute via the dopamine D

Identifiants

pubmed: 32508577
doi: 10.3389/fnins.2020.00484
pmc: PMC7251943
doi:

Types de publication

Journal Article

Langues

eng

Pagination

484

Subventions

Organisme : Medical Research Council
ID : MR/N025377/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N026063/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 Andersen, Raghava, Svarer, Wulff, Johansen, Antonsen, Nielsen, Rostrup, Vernon, Jensen, Pinborg, Glenthøj and Ebdrup.

Références

Acta Psychiatr Scand. 2009 Dec;120(6):416-28
pubmed: 19573049
Arch Gen Psychiatry. 2012 Dec;69(12):1195-204
pubmed: 22868877
Wien Med Wochenschr. 2008;158(3-4):84-90
pubmed: 18330524
Schizophr Res. 2005 Nov 15;79(2-3):231-8
pubmed: 15982856
Neuroimage. 2018 Aug 1;176:226-238
pubmed: 29704613
Schizophr Res. 2014 Nov;159(2-3):411-4
pubmed: 25278103
Psychopharmacology (Berl). 2001 Sep;157(3):236-42
pubmed: 11605078
Aust N Z J Psychiatry. 2017 May;51(5):500-508
pubmed: 28415873
Curr Pharm Des. 2009;15(22):2550-9
pubmed: 19689327
Psychiatry Res. 2007 Apr 15;154(3):199-208
pubmed: 17360162
Neuroimage. 2005 Feb 15;24(4):969-79
pubmed: 15670674
Curr Med Chem. 2013;20(3):438-47
pubmed: 23157636
JAMA Psychiatry. 2015 Sep;72(9):927-34
pubmed: 26131622
Biol Psychiatry. 2002 Nov 1;52(9):855-62
pubmed: 12399138
Eur Neuropsychopharmacol. 2015 Nov;25(11):2098-107
pubmed: 26321204
Schizophr Res. 2012 Sep;140(1-3):214-20
pubmed: 22795368
Lancet Psychiatry. 2018 Oct;5(10):797-807
pubmed: 30115598
Schizophr Bull. 2015 Jan;41(1):44-56
pubmed: 25249654
Science. 1976 Apr 30;192(4238):481-3
pubmed: 3854
Neurosci Biobehav Rev. 2017 May;76(Pt B):317-335
pubmed: 27756689
Braz J Psychiatry. 2015 Jan-Mar;37(1):71-9
pubmed: 25806554
J Clin Psychopharmacol. 2011 Apr;31(2):146-53
pubmed: 21346618
Neurosci Biobehav Rev. 2013 Sep;37(8):1680-91
pubmed: 23769814
Psychol Med. 2012 Jul;42(7):1475-83
pubmed: 22030695
Curr Neuropharmacol. 2015;13(4):422-34
pubmed: 26412062
J Clin Psychopharmacol. 2013 Oct;33(5):682-5
pubmed: 23899638
Mol Psychiatry. 2016 Apr;21(4):547-53
pubmed: 26033243
Sci Rep. 2019 May 24;9(1):7850
pubmed: 31127135
Am J Psychiatry. 2003 Jan;160(1):13-23
pubmed: 12505794
Hum Psychopharmacol. 2017 Mar;32(2):
pubmed: 28370309
Schizophr Bull. 2013 Sep;39(5):1129-38
pubmed: 23042112
Psychol Med. 2020 Jan;50(2):220-228
pubmed: 30642415
Curr Med Chem. 2013;20(3):397-404
pubmed: 23157632
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Schizophr Bull. 2015 Sep;41(5):1143-52
pubmed: 25698711
Eur Neuropsychopharmacol. 2010 Jul;20(7):454-8
pubmed: 20227855
Schizophr Res. 2019 Jun;208:114-123
pubmed: 31006616
Biol Psychiatry. 2014 Jun 15;75(12):982-90
pubmed: 24143881
Expert Rev Neurother. 2010 Jan;10(1):33-42
pubmed: 20021319
Psychiatry Clin Neurosci. 2015 May;69(5):243-58
pubmed: 25296946
Biol Psychiatry. 2012 May 15;71(10):855-63
pubmed: 22244831
Curr Neuropharmacol. 2017;15(1):174-183
pubmed: 27264948
JAMA Psychiatry. 2017 Nov 1;74(11):1104-1111
pubmed: 28973084
Neuroimage. 2011 Jun 1;56(3):907-22
pubmed: 21352927
Hum Brain Mapp. 2018 Jan;39(1):319-331
pubmed: 29058358
Int J Mol Sci. 2015 Dec 17;16(12):30144-63
pubmed: 26694375
Arch Gen Psychiatry. 2012 Aug;69(8):776-86
pubmed: 22474070
J Nucl Med. 1990 May;31(5):573-9
pubmed: 2140408
Eur Arch Psychiatry Clin Neurosci. 2016 Aug;266(5):451-60
pubmed: 26547434
Hum Psychopharmacol. 2002 Jan;17(1):1-13
pubmed: 12404702
Schizophr Bull. 2009 May;35(3):549-62
pubmed: 19325164
Int J Neuropsychopharmacol. 2011 Feb;14(1):69-82
pubmed: 20701823
Addict Biol. 2012 Jul;17(4):817-25
pubmed: 21392170
J Clin Psychopharmacol. 2011 Aug;31(4):497-502
pubmed: 21694629
JAMA Psychiatry. 2015 Jan;72(1):5-13
pubmed: 25372846

Auteurs

Helle G Andersen (HG)

Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research and Center for Neuropsychiatric Schizophrenia Research, Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Jayachandra M Raghava (JM)

Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research and Center for Neuropsychiatric Schizophrenia Research, Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.
Functional Imaging Unit, Department of Clinical Physiology, Nuclear Medicine and PET, University of Copenhagen, Glostrup, Denmark.

Claus Svarer (C)

Neurobiology Research Unit, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Sanne Wulff (S)

Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research and Center for Neuropsychiatric Schizophrenia Research, Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.

Louise B Johansen (LB)

Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research and Center for Neuropsychiatric Schizophrenia Research, Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.

Patrick K Antonsen (PK)

Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research and Center for Neuropsychiatric Schizophrenia Research, Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Mette Ø Nielsen (MØ)

Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research and Center for Neuropsychiatric Schizophrenia Research, Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Egill Rostrup (E)

Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research and Center for Neuropsychiatric Schizophrenia Research, Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.

Anthony C Vernon (AC)

Department of Basic and Clinical Neuroscience, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, United Kingdom.
Medical Research Council Centre for Neurodevelopmental Disorders, King's College London, London, United Kingdom.

Lars T Jensen (LT)

Department of Clinical Physiology and Nuclear Medicine, Herlev Hospital, University of Copenhagen, Herlev, Denmark.

Lars H Pinborg (LH)

Neurobiology Research Unit, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Birte Y Glenthøj (BY)

Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research and Center for Neuropsychiatric Schizophrenia Research, Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Bjørn H Ebdrup (BH)

Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research and Center for Neuropsychiatric Schizophrenia Research, Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Classifications MeSH